|
- Home Page - pluri-biotech. com
Pluri is a global leader in 3D cell-expansion technology, developing platforms to manufacture the products and solutions of the future Since 2003, we’ve been expanding cells to accelerate the development of pharmaceutical product candidates
- INVESTORS ESG - pluri-biotech. com
Pluri Inc is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability
- OUR TECHNOLOGY - pluri-biotech. com
Our large portfolio of issued patents and pending patent applications spans over 52 countries, including over 250 patents Pluri continues to file new patent applications covering our ongoing R D areas, offering a significant commercial advantage in key markets
- Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc. ” Reflecting . . .
Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability
- PRESS Releases - pluri-biotech. com
Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel Click Here
- Leading Global Players Back and Fund Pluri’s Cell-Based Food and . . .
Pluri’s momentum comes at a critical moment, with demand for sustainable solutions for traditional agriculture on the rise amid challenges such as warming climates, dwindling natural resources, and an increasing global population
- CLINICAL PIPELINE - pluri-biotech. com
The FDA has cleared Pluri’s Investigational New Drug (IND) application for PLX-R18 in the treatment of ARS The IND allows Pluri to treat victims who may have been acutely exposed to high dose radiation due to nuclear attacks or accident
- Pluri Completes Strategic Acquisition of Leading Cultivated Cacao . . .
Pluri™ is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global well-being and sustainability
|
|
|